Vaxxinity Performance
| VAXXDelisted Stock | USD 2.72 0.19 6.53% |
The entity has a beta of 0.29, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Vaxxinity's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vaxxinity is expected to be smaller as well. Vaxxinity right now has a risk of 0.0%. Please validate Vaxxinity maximum drawdown, skewness, as well as the relationship between the Skewness and day typical price , to decide if Vaxxinity will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vaxxinity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Vaxxinity is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 34.6 M |
Vaxxinity |
Vaxxinity Relative Risk vs. Return Landscape
If you would invest 272.00 in Vaxxinity on April 28, 2024 and sell it today you would earn a total of 0.00 from holding Vaxxinity or generate 0.0% return on investment over 90 days. Vaxxinity is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Vaxxinity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vaxxinity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxxinity's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Vaxxinity, and traders can use it to determine the average amount a Vaxxinity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VAXX |
Based on monthly moving average Vaxxinity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxxinity by adding Vaxxinity to a well-diversified portfolio.
Vaxxinity Fundamentals Growth
Vaxxinity Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vaxxinity, and Vaxxinity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vaxxinity Pink Sheet performance.
| Return On Equity | -1.51 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (1.39 M) | ||||
| Shares Outstanding | 112.91 M | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 4,605 X | ||||
| EBITDA | (56.05 M) | ||||
| Cash And Equivalents | 128.23 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.09 % | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (57.24 M) | ||||
| Earnings Per Share | (0.45) X | ||||
| Total Asset | 44.35 M | ||||
| Retained Earnings | (361.64 M) | ||||
About Vaxxinity Performance
Evaluating Vaxxinity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Vaxxinity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vaxxinity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.Things to note about Vaxxinity performance evaluation
Checking the ongoing alerts about Vaxxinity for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vaxxinity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vaxxinity is not yet fully synchronised with the market data | |
| Vaxxinity has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (56.93 M) with loss before overhead, payroll, taxes, and interest of (1.87 M). | |
| Vaxxinity currently holds about 128.23 M in cash with (57.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02. | |
| Roughly 51.0% of the company outstanding shares are owned by insiders |
- Analyzing Vaxxinity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vaxxinity's stock is overvalued or undervalued compared to its peers.
- Examining Vaxxinity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vaxxinity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vaxxinity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vaxxinity's pink sheet. These opinions can provide insight into Vaxxinity's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |